000 01607 a2200397 4500
005 20250516202832.0
264 0 _c20140929
008 201409s 0 0 eng d
022 _a1439-099X
024 7 _a10.1007/s00066-014-0637-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaier, Patrick
245 0 0 _aRadioprotection of normal tissue cells.
_h[electronic resource]
260 _bStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
_cAug 2014
300 _a745-52 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aAmifostine
_xpharmacology
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDNA Damage
_xdrug effects
650 0 4 _aDose Fractionation, Radiation
650 0 4 _aFibroblast Growth Factor 7
_xpharmacology
650 0 4 _aFree Radical Scavengers
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLinear Energy Transfer
650 0 4 _aOtorhinolaryngologic Neoplasms
_xpathology
650 0 4 _aRadiation Injuries
_xpathology
650 0 4 _aRadiation-Protective Agents
_xpharmacology
650 0 4 _aReactive Oxygen Species
_xradiation effects
650 0 4 _aTumor Cells, Cultured
_xdrug effects
650 0 4 _aWhole-Body Irradiation
_xadverse effects
700 1 _aWenz, Frederik
700 1 _aHerskind, Carsten
773 0 _tStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
_gvol. 190
_gno. 8
_gp. 745-52
856 4 0 _uhttps://doi.org/10.1007/s00066-014-0637-x
_zAvailable from publisher's website
999 _c23648927
_d23648927